 |
 |
 |
 |
 |
 |
 |
Homebased Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD)
This study is currenly Recruiting patients.
Sponsored by:
St. Olavs Hospital
Purpose
We want to improve the treatment of patients suffering from COPD (3-4) by early medical
intervention in the patients home. A close cooperation between the hospital and the primary
healthcare system will hopefully reduce hospitalisation, drug consumption and improve
quality of life.
The first main outcome variable will be number of hospitalizations assessed simply by
counting. The second objective will be Quality of life and activation assessed by different
questionnaires included in St.George´s Respiratory Questionnaire.
Study Type: Intervention
| Condition | Intervention | Phase |
|
COPD |
Behavioral: closer collaboration between hospital and primary healthcare system | N/A |
Study Design:Allocation: Randomized, Control: Uncontrolled, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Official Title: Randomised Clinical Study on the Effect of Homebased Treatment of Patients With COPD. Improved Cooperation Between Hospital and Primary Healthcare System.
Further Study Details:
Expected Total Enrollment:
Study Dates:April 2008 -
Eligibility
Ages Eligible for Study- Min: N/A Max: 95 Years
Gender: Both
Criteria
Inclusion Criteria:
clinical diagnosis of COPD (III-IV)
receive help from homecare nurse
not suffering from any other serious disease, with expected lifespan less than 6
months
Exclusion Criteria:
-
Inclusion Criteria:
months
Exclusion Criteria:
-
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier: NCT00702078
Dept. of Lung Diseases, St.Olavs Hospital - Trondheim, 7006
Anne Henriksen, MD, PhD +47 73 86 85 79 anne.henriksen@stolav.no
More Information
Record Last Reviewed:June 2008
Last Updated:June 19, 2008
Record First Recieved:June 19, 2008
ClinicalTrials.gov Identifier:NCT00702078
Health Authority: United States Food and Drug Administration
Information obtained from ClinicalTrials.gov on September 08, 2010
 |
 |